INSIGHT REPORT CALENDAR

NEWSLETTER

Like this article?

Sign up to our free newsletter

British Patient Capital invests in graphene-specialist Paragraf

British Patient Capital has participated in the USD60 million Series B funding round of Paragraf, a Cambridge-based graphene-based electronics company.

This investment is being made through British Patient Capital’s Future Fund: Breakthrough programme, a GBP375 million initiative where British Patient Capital co-invests alongside private sector investors in later stage R&D-intensive UK companies.

Paragraf develops and delivers game-changing, commercial-quality, graphene-based electronic devices using contamination-free technology that is both scalable and compatible with existing electronic device manufacturing production processes.

Like this article? Sign up to our free newsletter

FEATURED

Tech Stocks

MOST RECENT

FURTHER READING